IgorElmanMD

Psychiatry • Belmont, MA

Addiction

Associate Professor of Psychiatry, Cambridge Health Alliance

Join to view full profile

Dr. Elman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Elman's full profile

Already have an account?

Office
115 Mill Street
Mclean Hospital/Bprl
Belmont, MA 02478
Phone+1 617-855-3692

Education & Training

Montefiore Medical Center/Albert Einstein College of MedicineResidency, Psychiatry, 1991 - 1995
Ben Gurion University of the NegevClass of 1990

Certifications & Licensure

OH State Medical License 2015 - 2027
DC State Medical License 1994 - 2026
MA State Medical License 1997 - 2026
NJ State Medical License 2018 - 2021
American Board of Psychiatry and Neurology Psychiatry
American Board of Psychiatry and Neurology Addiction Psychiatry

Clinical Trials

Augmenting Zyprexa With Naltrexone to Ameliorate Metabolic Side-Effects Start of enrollment: 2006 Dec 01
Completed
Phase 1
Generalized Anxiety and Seroquel Start of enrollment: 2010 Feb 01
Terminated
Not Applicable
Post-Traumatic Stress Disorder (PTSD) and Seroquel Start of enrollment: 2010 Feb 01
Completed
Not Applicable

Publications & Presentations

PubMed

In Silico Pharmacogenomic Assessment of Glucagon-like Peptide-1 (GLP1) Agonists and the Genetic Addiction Risk Score (GARS) Related Pathways: Implications for Suicide ...
Alireza Sharafshah, Kai-Uwe Lewandrowski, Mark S Gold, Brian Fuehrlein, J Wes Ashford
Current Neuropharmacology. 2025-01-24
Response to the SAMHSA Clinical Advisory: Considerations for Genetic Testing in the Assessment of Substance Use Disorder Risk.
Richard Paul Green, Kenneth Blum, Kai Uwe Lewandrowski, Mark S Gold, Alexander P L Lewandrowski
Substance Abuse and Rehabilitation. 2025-01-01
Evidence Based Clinical Analytics Supporting the Genetic Addiction Risk Severity (GARS) Assessment to Early Identify Probands in Preaddiction.
Kenneth Blum, Abdalla Bowirrat, Panayotis K Thanos, Colin Hanna, Jag Khalsa
EC Psychology and Psychiatry. 2024-12-26

Press Mentions

New Wright State Psychiatry Head Sets Sights on Complete Treatment for AddictionDecember 14th, 2015

Grant Support

PTSD And Drug Dependence: Neuroimaging Of Reward CircuitryNational Institute On Drug Abuse2007
PTSD And Drug Dependence: Neuroimaging Of Reward Circui*National Institute On Drug Abuse2004–2007
Neuroimaging Of Drug Craving In Cocaine DependenceNational Institute On Drug Abuse2002–2003
Neuroimaging Of Drug Craving In Cocaine DependenceNational Institute On Drug Abuse2001–2002